Bilirubin oxidation products (BOXes) have been a subject of interest in neurosurgery because they are purported to be involved in subarachnoid hemorrhage induced cerebral vasospasm. There is a growing body of information concerning their putative role in vasospasm; however, there is a dearth of information concerning the chemical and biochemical characteristics of BOXes. A clearer understanding of the synthesis, stability and characteristics of BOXes will be important for a better understanding of the role of BOXes post subarachnoid hemorrhage.
Introduction
There is extensive study of the oxidations (including peroxidations) of unsaturated lipids and proteins in biological systems, including the resultant compounds produced [1, 26, 39, 41] . There is also evidence that bilirubin is a biologic antioxidant [34, [43] [44] [45] [46] 51] . The oxidation of (unconjugated) bilirubin has largely focused on the degradation of bilirubin between the pyrroles [5] , with little discussion concerning the putative biological activity of the products of bilirubin oxidation [49] . We recently reported on a new family of bilirubin oxidation products found following subarachnoid hemorrhage [3, 22, 25, 38 ]. It appears that bilirubin oxidation products (BOXes) can be formed by the direct, nonenzymatic oxidation of bilirubin with hydrogen peroxide [22] . In Fig. 1a we see the relationship between the EE form of bilirubin and the resultant BOXes produced by oxidation (adapted from Kranc et al. [22] . Cleavage of bilirubin at the pyrrole, rather than between the pyrrole rings produces an apparently reactive monopyrrole amide [22] . However, to date there has been relatively little information concerning the stability or characteristics of BOXes, which is important in understanding the role BOXes may play in subarachnoid haemorrhage induced vasospasm. Here we present our latest findings concerning the chemical characteristics of BOXes produced by the oxidation of bilirubin. The relatively unique characteristics of BOXes and their nonspecific, nonenzymatic production provides important insight into the putative role of unconjugated bilirubin and its oxidation products in human pathology.
Methods and materials
All materials are available from common commercial sources and unless noted were ACS Grade or better. Bilirubin (mixed isomers) was purchased from Sigma=Aldrich Chemical Company. Sodium hydroxide, hydrochloric acid, acetonitrile (HPLC grade), H 2 O 2 30% and Whatman Correspondence: Joseph F. Clark, Department of Neurology, University of Cincinnati, Cincinnati, OH 45267-0536, U.S.A. e-mail: joseph.clark@uc.edu I filter paper were obtained from Fisher Scientific. Water (18 m) was generated using a Biocel Millipore system.
Synthesis method for BOXes
In order to prepare BOXes by non-enzymatic oxidation, 100 mg of mixed isomers of bilirubin in is dissolved in 50 ml of water containing 10 g of sodium hydroxide (in 50 ml cell culture bottle with lid, taped or covered with foil). The solubilization is performed protected from light at room temperature and is completed in 24 h. The subsequent steps are carried out in the dark or protected from light. After 24 h, 23 ml of concentrated hydrochloric acid is added to the solubilized solution. The resultant solution is stirred and allowed to cool. Upon cooling to room temperature, the pH of the solution is taken. The solution is then brought to pH 7.5 by the careful addition of dilute hydrochloric acid.
After adding the hydrochloric acid to neutralize the solution, 1 PBS tablet (capable of making 200 ml of PBS aqueous) is added to the bilirubin solution. The resultant solution, once neutralized to pH 7.5, has sufficient buffering capacity to maintain the pH at 7.5 during the oxidation. If the solution is unbuffered, due to the Fenton-like nature of the reaction, the pH will drift up from 7.5 to 8.2 during the course of the reaction.
Next, the volume of the solution is measured in a graduated cylinder and hydrogen peroxide added to a final concentration of $10% hydrogen peroxide. After 24 h of stirring at room temperature, the resultant yellowish solution is frozen at À80 C. The frozen solution is then lypholyzed overnight, producing a yellow solid. The yellowish solid is then thoroughly triturated with 100 ml of chloroform. The chloroform solution is then filtered using Whatman 1 and a Hirsch Funnel. The filtrate is evaporated under nitrogen gas. This produces about 4% by weight of BOXes.
HPLC analysis
HPLC analysis was performed using a Waters Chromatography System consisting of a 2790 Separations Module and 2487 Variable Wavelength Detector running Millennium 32 Data Analysis Software. Separation was achieved on a Symmetry C18, 5 mm 4.6Â 150 mm, column. The elutant was monitored at 310 nm. Column temperature was held at 35 degrees centigrade with a flow rate of 1.0 ml=min. The mobile phase consisted of acetonitrile=water with a gradient of 5% to 50% acetonitrile being used.
Mass spectrometry
HPLC-MS analysis was performed on a Bruker Daltronics system using conditions identical to the above, with the exception of the gradient being 20% to 63% acetonitrile over 15 min with the acetonitrile being held constant until the end of the run. The MS was performed using air pressure chemical ionization in the negative ion mode with simultaneous monitoring at 254 nm.
Photostability study
Approximately 0.1 mg of BOXes was dissolved in 1 ml of phosphate buffered saline (PBS) at pH 7.5. The solution was exposed to various experimental conditions. Samples were taken at 30 min intervals for 120 min and the resultant samples were diluted 50:50 with PBS and the spectra read from 250 to 550 nm. For spectrometry, we used a mQuant plate reader and BD Falcon 96 well microplate. The data reported used the OD at 310 nm.
Results

BOXes production
We consistently observe a 4% yield for producing the mixture of BOXes (4-methyl-5-oxo-3-vinyl-(1,5-dihydropyrrol-2-ylidene)acetamide (BOX A) and 3-methyl-5-oxo-4-vinyl-(1,5-dihydropyrrol-2-ylidene)acetamide Fig. 1a . In this figure the EE form of bilirubin is represented along with the structures of BOXes that are likely to be produced. BOX A and BOX B can be produced by the oxidation of bilirubin. The resultant BOXes also have the E stereoisomer connecting the pyrrole to the amide based on the prediction of Kranc et al. [22] 44 W. L. Wurster et al.
